Suppr超能文献

相似文献

1
Redefining the viral reservoirs that prevent HIV-1 eradication.
Immunity. 2012 Sep 21;37(3):377-88. doi: 10.1016/j.immuni.2012.08.010.
3
The challenge of viral reservoirs in HIV-1 infection.
Annu Rev Med. 2002;53:557-93. doi: 10.1146/annurev.med.53.082901.104024.
5
Cellular reservoirs of HIV-1 and their role in viral persistence.
Curr HIV Res. 2008 Sep;6(5):388-400. doi: 10.2174/157016208785861195.
6
LGIT In Vitro Latency Model in Primary and T Cell Lines to Test HIV-1 Reactivation Compounds.
Methods Mol Biol. 2016;1354:255-64. doi: 10.1007/978-1-4939-3046-3_17.
7
The role of cytokines in the establishment, persistence and eradication of the HIV reservoir.
Cytokine Growth Factor Rev. 2012 Aug-Oct;23(4-5):143-9. doi: 10.1016/j.cytogfr.2012.05.001. Epub 2012 Jun 27.
10
Are T cells the only HIV-1 reservoir?
Retrovirology. 2016 Dec 20;13(1):86. doi: 10.1186/s12977-016-0323-4.

引用本文的文献

2
Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.
Adv Sci (Weinh). 2025 Aug;12(32):e15678. doi: 10.1002/advs.202415678. Epub 2025 Jul 4.
3
HIV-1 latency: From acquaintance to confidant.
J Virus Erad. 2025 May 20;11(2):100597. doi: 10.1016/j.jve.2025.100597. eCollection 2025 Jun.
5
SLC38A9 is directly involved in Tat-induced endolysosome dysfunction and senescence in astrocytes.
Life Sci Alliance. 2025 May 5;8(7). doi: 10.26508/lsa.202503231. Print 2025 Jul.
7
Cannabis Use in HIV: Impact on Inflammation, Immunity and the Microbiome.
Curr HIV/AIDS Rep. 2025 Feb 22;22(1):19. doi: 10.1007/s11904-025-00729-0.
8
Inhibition of TIGIT on NK cells improves their cytotoxicity and HIV reservoir eradication potential.
mBio. 2025 Mar 12;16(3):e0322624. doi: 10.1128/mbio.03226-24. Epub 2025 Feb 7.
9
Phenotyping Viral Reservoirs to Reveal HIV-1 Hiding Places.
Curr HIV/AIDS Rep. 2025 Feb 4;22(1):15. doi: 10.1007/s11904-025-00723-6.
10
The Proviral Reservoirs of Human Immunodeficiency Virus (HIV) Infection.
Pathogens. 2024 Dec 30;14(1):15. doi: 10.3390/pathogens14010015.

本文引用的文献

1
Developing strategies for HIV-1 eradication.
Trends Immunol. 2012 Nov;33(11):554-62. doi: 10.1016/j.it.2012.07.001. Epub 2012 Aug 3.
2
Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.
Nature. 2012 Jul 25;487(7408):482-5. doi: 10.1038/nature11286.
3
Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation.
Immunity. 2012 Mar 23;36(3):491-501. doi: 10.1016/j.immuni.2012.01.014. Epub 2012 Mar 8.
4
A quantitative basis for antiretroviral therapy for HIV-1 infection.
Nat Med. 2012 Feb 19;18(3):446-51. doi: 10.1038/nm.2649.
5
HIV compartmentalization: a review on a clinically important phenomenon.
Curr HIV Res. 2012 Mar;10(2):133-42. doi: 10.2174/157016212799937245.
8
HIV latency.
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a007096. doi: 10.1101/cshperspect.a007096.
9
Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID.
Proc Natl Acad Sci U S A. 2011 Dec 13;108(50):20166-71. doi: 10.1073/pnas.1110064108. Epub 2011 Nov 30.
10
Microglial cell origin and phenotypes in health and disease.
Nat Rev Immunol. 2011 Oct 25;11(11):775-87. doi: 10.1038/nri3086.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验